1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Stimulant 1.2.3 Non-stimulant 1.3 Market by Application 1.3.1 Global Attention Deficit and Hyperactivity Disorder Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Hospital 1.3.3 Retail Pharmacy 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Attention Deficit and Hyperactivity Disorder Market Perspective (2018-2029) 2.2 Attention Deficit and Hyperactivity Disorder Growth Trends by Region 2.2.1 Global Attention Deficit and Hyperactivity Disorder Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Attention Deficit and Hyperactivity Disorder Historic Market Size by Region (2018-2023) 2.2.3 Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Region (2024-2029) 2.3 Attention Deficit and Hyperactivity Disorder Market Dynamics 2.3.1 Attention Deficit and Hyperactivity Disorder Industry Trends 2.3.2 Attention Deficit and Hyperactivity Disorder Market Drivers 2.3.3 Attention Deficit and Hyperactivity Disorder Market Challenges 2.3.4 Attention Deficit and Hyperactivity Disorder Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Attention Deficit and Hyperactivity Disorder Players by Revenue 3.1.1 Global Top Attention Deficit and Hyperactivity Disorder Players by Revenue (2018-2023) 3.1.2 Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Players (2018-2023) 3.2 Global Attention Deficit and Hyperactivity Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Attention Deficit and Hyperactivity Disorder Revenue 3.4 Global Attention Deficit and Hyperactivity Disorder Market Concentration Ratio 3.4.1 Global Attention Deficit and Hyperactivity Disorder Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Attention Deficit and Hyperactivity Disorder Revenue in 2022 3.5 Attention Deficit and Hyperactivity Disorder Key Players Head office and Area Served 3.6 Key Players Attention Deficit and Hyperactivity Disorder Product Solution and Service 3.7 Date of Enter into Attention Deficit and Hyperactivity Disorder Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Attention Deficit and Hyperactivity Disorder Breakdown Data by Type 4.1 Global Attention Deficit and Hyperactivity Disorder Historic Market Size by Type (2018-2023) 4.2 Global Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Type (2024-2029) 5 Attention Deficit and Hyperactivity Disorder Breakdown Data by Application 5.1 Global Attention Deficit and Hyperactivity Disorder Historic Market Size by Application (2018-2023) 5.2 Global Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Attention Deficit and Hyperactivity Disorder Market Size (2018-2029) 6.2 North America Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Attention Deficit and Hyperactivity Disorder Market Size by Country (2018-2023) 6.4 North America Attention Deficit and Hyperactivity Disorder Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Attention Deficit and Hyperactivity Disorder Market Size (2018-2029) 7.2 Europe Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Attention Deficit and Hyperactivity Disorder Market Size by Country (2018-2023) 7.4 Europe Attention Deficit and Hyperactivity Disorder Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size (2018-2029) 8.2 Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size by Region (2018-2023) 8.4 Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Attention Deficit and Hyperactivity Disorder Market Size (2018-2029) 9.2 Latin America Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Attention Deficit and Hyperactivity Disorder Market Size by Country (2018-2023) 9.4 Latin America Attention Deficit and Hyperactivity Disorder Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size (2018-2029) 10.2 Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size by Country (2018-2023) 10.4 Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Takeda 11.1.1 Takeda Company Detail 11.1.2 Takeda Business Overview 11.1.3 Takeda Attention Deficit and Hyperactivity Disorder Introduction 11.1.4 Takeda Revenue in Attention Deficit and Hyperactivity Disorder Business (2018-2023) 11.1.5 Takeda Recent Development 11.2 Johnson & Johnson 11.2.1 Johnson & Johnson Company Detail 11.2.2 Johnson & Johnson Business Overview 11.2.3 Johnson & Johnson Attention Deficit and Hyperactivity Disorder Introduction 11.2.4 Johnson & Johnson Revenue in Attention Deficit and Hyperactivity Disorder Business (2018-2023) 11.2.5 Johnson & Johnson Recent Development 11.3 Novartis 11.3.1 Novartis Company Detail 11.3.2 Novartis Business Overview 11.3.3 Novartis Attention Deficit and Hyperactivity Disorder Introduction 11.3.4 Novartis Revenue in Attention Deficit and Hyperactivity Disorder Business (2018-2023) 11.3.5 Novartis Recent Development 11.4 Eli Lilly 11.4.1 Eli Lilly Company Detail 11.4.2 Eli Lilly Business Overview 11.4.3 Eli Lilly Attention Deficit and Hyperactivity Disorder Introduction 11.4.4 Eli Lilly Revenue in Attention Deficit and Hyperactivity Disorder Business (2018-2023) 11.4.5 Eli Lilly Recent Development 11.5 Tris Pharma 11.5.1 Tris Pharma Company Detail 11.5.2 Tris Pharma Business Overview 11.5.3 Tris Pharma Attention Deficit and Hyperactivity Disorder Introduction 11.5.4 Tris Pharma Revenue in Attention Deficit and Hyperactivity Disorder Business (2018-2023) 11.5.5 Tris Pharma Recent Development 11.6 Neos Therapeutics 11.6.1 Neos Therapeutics Company Detail 11.6.2 Neos Therapeutics Business Overview 11.6.3 Neos Therapeutics Attention Deficit and Hyperactivity Disorder Introduction 11.6.4 Neos Therapeutics Revenue in Attention Deficit and Hyperactivity Disorder Business (2018-2023) 11.6.5 Neos Therapeutics Recent Development 11.7 Mallinckrodt 11.7.1 Mallinckrodt Company Detail 11.7.2 Mallinckrodt Business Overview 11.7.3 Mallinckrodt Attention Deficit and Hyperactivity Disorder Introduction 11.7.4 Mallinckrodt Revenue in Attention Deficit and Hyperactivity Disorder Business (2018-2023) 11.7.5 Mallinckrodt Recent Development 11.8 Amneal Pharmaceuticals 11.8.1 Amneal Pharmaceuticals Company Detail 11.8.2 Amneal Pharmaceuticals Business Overview 11.8.3 Amneal Pharmaceuticals Attention Deficit and Hyperactivity Disorder Introduction 11.8.4 Amneal Pharmaceuticals Revenue in Attention Deficit and Hyperactivity Disorder Business (2018-2023) 11.8.5 Amneal Pharmaceuticals Recent Development 11.9 Noven Pharmaceuticals 11.9.1 Noven Pharmaceuticals Company Detail 11.9.2 Noven Pharmaceuticals Business Overview 11.9.3 Noven Pharmaceuticals Attention Deficit and Hyperactivity Disorder Introduction 11.9.4 Noven Pharmaceuticals Revenue in Attention Deficit and Hyperactivity Disorder Business (2018-2023) 11.9.5 Noven Pharmaceuticals Recent Development 11.10 Purdue Parma 11.10.1 Purdue Parma Company Detail 11.10.2 Purdue Parma Business Overview 11.10.3 Purdue Parma Attention Deficit and Hyperactivity Disorder Introduction 11.10.4 Purdue Parma Revenue in Attention Deficit and Hyperactivity Disorder Business (2018-2023) 11.10.5 Purdue Parma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Stimulant Table 3. Key Players of Non-stimulant Table 4. Global Attention Deficit and Hyperactivity Disorder Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 5. Global Attention Deficit and Hyperactivity Disorder Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 6. Global Attention Deficit and Hyperactivity Disorder Market Size by Region (2018-2023) & (US$ Million) Table 7. Global Attention Deficit and Hyperactivity Disorder Market Share by Region (2018-2023) Table 8. Global Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 9. Global Attention Deficit and Hyperactivity Disorder Market Share by Region (2024-2029) Table 10. Attention Deficit and Hyperactivity Disorder Market Trends Table 11. Attention Deficit and Hyperactivity Disorder Market Drivers Table 12. Attention Deficit and Hyperactivity Disorder Market Challenges Table 13. Attention Deficit and Hyperactivity Disorder Market Restraints Table 14. Global Attention Deficit and Hyperactivity Disorder Revenue by Players (2018-2023) & (US$ Million) Table 15. Global Attention Deficit and Hyperactivity Disorder Market Share by Players (2018-2023) Table 16. Global Top Attention Deficit and Hyperactivity Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit and Hyperactivity Disorder as of 2022) Table 17. Ranking of Global Top Attention Deficit and Hyperactivity Disorder Companies by Revenue (US$ Million) in 2022 Table 18. Global 5 Largest Players Market Share by Attention Deficit and Hyperactivity Disorder Revenue (CR5 and HHI) & (2018-2023) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Attention Deficit and Hyperactivity Disorder Product Solution and Service Table 21. Date of Enter into Attention Deficit and Hyperactivity Disorder Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Attention Deficit and Hyperactivity Disorder Market Size by Type (2018-2023) & (US$ Million) Table 24. Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Type (2018-2023) Table 25. Global Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 26. Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Type (2024-2029) Table 27. Global Attention Deficit and Hyperactivity Disorder Market Size by Application (2018-2023) & (US$ Million) Table 28. Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Application (2018-2023) Table 29. Global Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 30. Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Application (2024-2029) Table 31. North America Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 32. North America Attention Deficit and Hyperactivity Disorder Market Size by Country (2018-2023) & (US$ Million) Table 33. North America Attention Deficit and Hyperactivity Disorder Market Size by Country (2024-2029) & (US$ Million) Table 34. Europe Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 35. Europe Attention Deficit and Hyperactivity Disorder Market Size by Country (2018-2023) & (US$ Million) Table 36. Europe Attention Deficit and Hyperactivity Disorder Market Size by Country (2024-2029) & (US$ Million) Table 37. Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 38. Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size by Region (2018-2023) & (US$ Million) Table 39. Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size by Region (2024-2029) & (US$ Million) Table 40. Latin America Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 41. Latin America Attention Deficit and Hyperactivity Disorder Market Size by Country (2018-2023) & (US$ Million) Table 42. Latin America Attention Deficit and Hyperactivity Disorder Market Size by Country (2024-2029) & (US$ Million) Table 43. Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 44. Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size by Country (2018-2023) & (US$ Million) Table 45. Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size by Country (2024-2029) & (US$ Million) Table 46. Takeda Company Detail Table 47. Takeda Business Overview Table 48. Takeda Attention Deficit and Hyperactivity Disorder Product Table 49. Takeda Revenue in Attention Deficit and Hyperactivity Disorder Business (2018-2023) & (US$ Million) Table 50. Takeda Recent Development Table 51. Johnson & Johnson Company Detail Table 52. Johnson & Johnson Business Overview Table 53. Johnson & Johnson Attention Deficit and Hyperactivity Disorder Product Table 54. Johnson & Johnson Revenue in Attention Deficit and Hyperactivity Disorder Business (2018-2023) & (US$ Million) Table 55. Johnson & Johnson Recent Development Table 56. Novartis Company Detail Table 57. Novartis Business Overview Table 58. Novartis Attention Deficit and Hyperactivity Disorder Product Table 59. Novartis Revenue in Attention Deficit and Hyperactivity Disorder Business (2018-2023) & (US$ Million) Table 60. Novartis Recent Development Table 61. Eli Lilly Company Detail Table 62. Eli Lilly Business Overview Table 63. Eli Lilly Attention Deficit and Hyperactivity Disorder Product Table 64. Eli Lilly Revenue in Attention Deficit and Hyperactivity Disorder Business (2018-2023) & (US$ Million) Table 65. Eli Lilly Recent Development Table 66. Tris Pharma Company Detail Table 67. Tris Pharma Business Overview Table 68. Tris Pharma Attention Deficit and Hyperactivity Disorder Product Table 69. Tris Pharma Revenue in Attention Deficit and Hyperactivity Disorder Business (2018-2023) & (US$ Million) Table 70. Tris Pharma Recent Development Table 71. Neos Therapeutics Company Detail Table 72. Neos Therapeutics Business Overview Table 73. Neos Therapeutics Attention Deficit and Hyperactivity Disorder Product Table 74. Neos Therapeutics Revenue in Attention Deficit and Hyperactivity Disorder Business (2018-2023) & (US$ Million) Table 75. Neos Therapeutics Recent Development Table 76. Mallinckrodt Company Detail Table 77. Mallinckrodt Business Overview Table 78. Mallinckrodt Attention Deficit and Hyperactivity Disorder Product Table 79. Mallinckrodt Revenue in Attention Deficit and Hyperactivity Disorder Business (2018-2023) & (US$ Million) Table 80. Mallinckrodt Recent Development Table 81. Amneal Pharmaceuticals Company Detail Table 82. Amneal Pharmaceuticals Business Overview Table 83. Amneal Pharmaceuticals Attention Deficit and Hyperactivity Disorder Product Table 84. Amneal Pharmaceuticals Revenue in Attention Deficit and Hyperactivity Disorder Business (2018-2023) & (US$ Million) Table 85. Amneal Pharmaceuticals Recent Development Table 86. Noven Pharmaceuticals Company Detail Table 87. Noven Pharmaceuticals Business Overview Table 88. Noven Pharmaceuticals Attention Deficit and Hyperactivity Disorder Product Table 89. Noven Pharmaceuticals Revenue in Attention Deficit and Hyperactivity Disorder Business (2018-2023) & (US$ Million) Table 90. Noven Pharmaceuticals Recent Development Table 91. Purdue Parma Company Detail Table 92. Purdue Parma Business Overview Table 93. Purdue Parma Attention Deficit and Hyperactivity Disorder Product Table 94. Purdue Parma Revenue in Attention Deficit and Hyperactivity Disorder Business (2018-2023) & (US$ Million) Table 95. Purdue Parma Recent Development Table 96. Research Programs/Design for This Report Table 97. Key Data Information from Secondary Sources Table 98. Key Data Information from Primary Sources List of Figures Figure 1. Global Attention Deficit and Hyperactivity Disorder Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Attention Deficit and Hyperactivity Disorder Market Share by Type: 2022 VS 2029 Figure 3. Stimulant Features Figure 4. Non-stimulant Features Figure 5. Global Attention Deficit and Hyperactivity Disorder Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 6. Global Attention Deficit and Hyperactivity Disorder Market Share by Application: 2022 VS 2029 Figure 7. Hospital Case Studies Figure 8. Retail Pharmacy Case Studies Figure 9. Others Case Studies Figure 10. Attention Deficit and Hyperactivity Disorder Report Years Considered Figure 11. Global Attention Deficit and Hyperactivity Disorder Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 12. Global Attention Deficit and Hyperactivity Disorder Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 13. Global Attention Deficit and Hyperactivity Disorder Market Share by Region: 2022 VS 2029 Figure 14. Global Attention Deficit and Hyperactivity Disorder Market Share by Players in 2022 Figure 15. Global Top Attention Deficit and Hyperactivity Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit and Hyperactivity Disorder as of 2022) Figure 16. The Top 10 and 5 Players Market Share by Attention Deficit and Hyperactivity Disorder Revenue in 2022 Figure 17. North America Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 18. North America Attention Deficit and Hyperactivity Disorder Market Share by Country (2018-2029) Figure 19. United States Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 20. Canada Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 21. Europe Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. Europe Attention Deficit and Hyperactivity Disorder Market Share by Country (2018-2029) Figure 23. Germany Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. France Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 25. U.K. Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. Italy Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. Russia Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Nordic Countries Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Share by Region (2018-2029) Figure 31. China Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Japan Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. South Korea Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Southeast Asia Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. India Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Australia Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. Latin America Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Latin America Attention Deficit and Hyperactivity Disorder Market Share by Country (2018-2029) Figure 39. Mexico Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Brazil Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Share by Country (2018-2029) Figure 43. Turkey Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Saudi Arabia Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. Takeda Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2018-2023) Figure 46. Johnson & Johnson Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2018-2023) Figure 47. Novartis Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2018-2023) Figure 48. Eli Lilly Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2018-2023) Figure 49. Tris Pharma Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2018-2023) Figure 50. Neos Therapeutics Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2018-2023) Figure 51. Mallinckrodt Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2018-2023) Figure 52. Amneal Pharmaceuticals Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2018-2023) Figure 53. Noven Pharmaceuticals Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2018-2023) Figure 54. Purdue Parma Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2018-2023) Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Takeda Johnson & Johnson Novartis Eli Lilly Tris Pharma Neos Therapeutics Mallinckrodt Amneal Pharmaceuticals Noven Pharmaceuticals Purdue Parma